This morning, NRx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Abbreviated New Drug Application (ANDA) for its preservative-free ketamine product, which it has previously called KETAFREE1. KETAFREE is a generic product, hence the ANDA pathway, and is thus approved with the same label as Ketalar, the first ketamine product approved by FDA.
EvanderOctober 30, 20261 min read
Curated by Paradise Farmers Market
Read the full story
Continue reading at Psychedelic Alpha
Originally reported by Evander at Psychedelic Alpha
Paradise Farmers Market curates content for educational purposes.
